echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Livzon's first hypoglycemic biologic medicine is here!

    Livzon's first hypoglycemic biologic medicine is here!

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On September 13th, Livzon submitted a clinical application for a new class of 3.


    Picture 1: Livzon's newly declared products

    Source: CDE official website

    Smeglutide is a human glucagon-like peptide-1 (GLP-1) analog, which promotes insulin secretion and inhibits glucagon secretion through a glucose concentration-dependent mechanism, which can increase the blood glucose level of patients with type 2 diabetes.


    Novo Nordisk has developed injection preparations (Ozempic) and oral preparations (Rybelsus) for smeglutide.


    Figure 2: The situation of domestic pharmaceutical companies that have submitted clinical applications earlier

    Source: Meinenet MED2.


    Zhuhai United Laboratories and Hangzhou Jiuyuan Genetic Engineering submitted clinical applications for Class 3.


    Recently, Livzon’s biopharmaceuticals under development have good news.


    Figure 3: Merck Gonafen's sales in public medical institutions in China (unit: ten thousand yuan)

    Source: Mi Nei.


    According to data from Mi Nei.


    Source: CDE official website, Minet database

    The review data statistics are as of September 14.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.